…One minister insisted the draft mustn’t be released until approved. Next moment, delegates from that country were in the press room giving copies to favoured journalists…
Pfizer/BioNTech, Moderna mRNA vaccinations ongoing. J&J approved, not ordered. Supply picking up. Not yet approved: AstraZeneca, Curevac and Novavax. Switzerland has ordered over 30m doses for 8m people
Pfizer/BioNTech, Moderna mRNA vaccinations ongoing. J&J approved, not ordered. Supply picking up. Approval waiting: AstraZeneca, Curevac and Novavax. Switzerland has ordered over 30m doses for 8m people
Pfizer/BioNTech, Moderna mRNA vaccinations ongoing. Supply picking up. Still waiting for approval: AstraZeneca, Curevac and Novavax. Switzerland has ordered over 30m doses for 8m people
Pfizer/BioNTech, Moderna mRNA vaccinations ongoing. Supply picking up. Still waiting for approval: AstraZeneca, Curevac and Novavax. Switzerland has ordered over 30m doses for 8m people
2/10
Vaccinations and virus variants
“Fully” = second dose
Steady growth, deliveries up
Delivered: 2.1m=23.9% (from 1.7m)
Administered: 1.4m=17.8% (from 1.2m)
Fully: 577K=6.7% (from 507K)
1. The WTO SPS Agreement is “as relevant and applicable today as [ever], and [continues] to safeguard the right for Members to take measures necessary for the protection of human, animal or plant life or health”
The SPS Committee improves implementation via transparency
2/4
2. But the world is changing. The draft proposes a new work programme (don’t yawn)—but not negotiating new obligations or amending the SPS Agreement
3. Interesting: the countries NOT on the list—eg EU, Iceland, Norway, Switzerland, UK. Why? …